Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mayo Clinic Laboratories, |
RCV001507461 | SCV001713044 | uncertain significance | not provided | 2020-01-09 | criteria provided, single submitter | clinical testing | |
Laboratory of Medical Genetics, |
RCV001729927 | SCV001976674 | likely pathogenic | Pyruvate kinase deficiency of red cells | 2021-10-01 | criteria provided, single submitter | clinical testing | PM1, PM2, PP2, PP3, PP5 |
Revvity Omics, |
RCV001507461 | SCV003809444 | likely pathogenic | not provided | 2023-06-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001507461 | SCV004292891 | uncertain significance | not provided | 2023-05-12 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt PKLR protein function. ClinVar contains an entry for this variant (Variation ID: 1162854). This missense change has been observed in individual(s) with pyruvate kinase deficiency (PMID: 7706479, 34008892). This variant is present in population databases (rs755522396, gnomAD 0.004%). This sequence change replaces glycine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 458 of the PKLR protein (p.Gly458Asp). |